Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Clinical trial NCT05084027 · UNKNOWN

Trial details

NCT number: NCT05084027
Sponsor: First Affiliated Hospital of Zhejiang University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy Older Patients Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2021-10-07
Primary completion: 2022-09-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.